CABL2_HUMAN - dbPTM
CABL2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CABL2_HUMAN
UniProt AC Q9BTV7
Protein Name CDK5 and ABL1 enzyme substrate 2
Gene Name CABLES2
Organism Homo sapiens (Human).
Sequence Length 478
Subcellular Localization
Protein Description Unknown. Probably involved in G1-S cell cycle transition..
Protein Sequence MAAAAAGGAPGPAPGPAGPPPPAAPTSAARAPPQALRRRGDSRRRQAALFFLNNISLDGRPPSLGPGGEKPPPPPAEAREPPAPPPPEPPTGLPARTPAPQGLLSPTQVPTGLGLDGQRQRKRVTSQRCSLEFLEDAVGCAPAQRTKHTSGSPRHKGLKKTHFIKNMRQYDTRNSRIVLICAKRSLCAAFSVLPYGEGLRISDLRVDSQKQRHPSGGVSVSSEMVFELEGVELGADGKVVSYAKFLYPTNALVTHKSDSHGLLPTPRPSVPRTLPGSRHKPAPTKSAPASTELGSDVGDTLEYNPNLLDDPQWPCGKHKRVLIFASYMTTVIEYVKPSDLKKDMNETFREKFPHVKLTLSKIRSLKREMRSLSEECSLEPVTVAMAYVYFEKLVLQGKLSKQNRKLCAGACVLLAAKISSDLRKSGVTQLIDKLEERFRFNRRDLIGFEFTVLVALELALYLPENQVLPHYRRLTQQF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
56PhosphorylationLFFLNNISLDGRPPS
HHHHHCCCCCCCCCC
23.6428348404
97PhosphorylationPTGLPARTPAPQGLL
CCCCCCCCCCCCCCC
26.3830266825
105PhosphorylationPAPQGLLSPTQVPTG
CCCCCCCCCCCCCCC
30.8330266825
107PhosphorylationPQGLLSPTQVPTGLG
CCCCCCCCCCCCCCC
38.5330266825
111PhosphorylationLSPTQVPTGLGLDGQ
CCCCCCCCCCCCCCH
46.3030266825
125PhosphorylationQRQRKRVTSQRCSLE
HHHHHCHHHCHHCHH
24.1523312004
126PhosphorylationRQRKRVTSQRCSLEF
HHHHCHHHCHHCHHH
16.8730624053
130PhosphorylationRVTSQRCSLEFLEDA
CHHHCHHCHHHHHHH
32.8722617229
149PhosphorylationPAQRTKHTSGSPRHK
CCCCCCCCCCCCCCC
36.0229514088
150PhosphorylationAQRTKHTSGSPRHKG
CCCCCCCCCCCCCCC
36.6718691976
152PhosphorylationRTKHTSGSPRHKGLK
CCCCCCCCCCCCCCC
20.6629514088
170PhosphorylationFIKNMRQYDTRNSRI
HHHHHHHHCCCCCEE
14.6622210691
172PhosphorylationKNMRQYDTRNSRIVL
HHHHHHCCCCCEEEE
27.1522210691
202PhosphorylationYGEGLRISDLRVDSQ
CCCCCCHHHEEECCC
24.9424719451
208PhosphorylationISDLRVDSQKQRHPS
HHHEEECCCCCCCCC
36.1028102081
257PhosphorylationNALVTHKSDSHGLLP
CEEEEECCCCCCCCC
36.4230266825
259PhosphorylationLVTHKSDSHGLLPTP
EEEECCCCCCCCCCC
26.9230266825
265PhosphorylationDSHGLLPTPRPSVPR
CCCCCCCCCCCCCCC
31.7223312004
269PhosphorylationLLPTPRPSVPRTLPG
CCCCCCCCCCCCCCC
46.1423312004
327PhosphorylationRVLIFASYMTTVIEY
EEEEEEEEEHHHHHH
8.61-
334PhosphorylationYMTTVIEYVKPSDLK
EEHHHHHHCCHHHHH
11.58-
361UbiquitinationHVKLTLSKIRSLKRE
CHHHHHHHHHHHHHH
45.30-
425PhosphorylationISSDLRKSGVTQLID
HCHHHHHCCHHHHHH
31.8725627689
428PhosphorylationDLRKSGVTQLIDKLE
HHHHCCHHHHHHHHH
22.6025627689
475O-linked_GlycosylationLPHYRRLTQQF----
CHHHHHHHHCC----
20.6529351928

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CABL2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CABL2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CABL2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CDK3_HUMANCDK3physical
11955625
CDK5_HUMANCDK5physical
11955625
ABL1_HUMANABL1physical
11955625

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CABL2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; THR-125; SER-126;SER-130 AND SER-208, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; SER-130 ANDSER-208, AND MASS SPECTROMETRY.

TOP